JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A4465 MIM1
1 Citation

Target: Mcl-1

Summary: Mcl-1 Inhibitor

insoluble in EtOH; insoluble in H2O; ≥12.15 mg/mL
B5846 Radotinib(IY-5511)

Target: PDGFR|Bcr-Abl

Summary: Bcr-Abl tyrosine kinase inhibitor

≥13.73 mg/mL
A8737 S63845
11 Citation

Target: MCL1

Summary: MCL1 inhibitor
A8168 HA14-1

Target: Bcl-2

Summary: Bcl-2 inhibitor,potent and cell-permeable

insoluble in H2O; ≥20.45 mg/mL
A8194 ABT-199
14 Citation

Target: Bcl-2

Summary: Bcl-2 inhibitor,potent and selective

≥43.42 mg/mL
A3007 ABT-263 (Navitoclax)
15 Citation

Target: Bcl-2|Bcl-w

Summary: Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w

≥48.73 mg/mL
A4234 TW-37
1 Citation

Target: Bcl-2|Bcl-xl|Mcl-1

Summary: Bcl-2 inhibitor, inhibits Bcl-2,Bcl-XL and Mcl-1

insoluble in H2O; ≥19.75 mg/mL
A4200 Apogossypolone (ApoG2)
2 Citation

Target: Bcl-2|Bcl-xl|Mcl-1

Summary: Bcl-2 inhibitor,nonpeptidic small molecule

≥24.55 mg/mL
A3935 WEHI-539
15 Citation

Target: Bcl-xl

Summary: Bcl-xL inhibitor,potent and selective

insoluble in DMSO; insoluble in H2O; insoluble in EtOH